SCHEMBL7320462

SCHEMBL7320462

O=Cc1ccccc1OCCN1CCCCC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.63
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
HRH1 P35367 4/20 0.61
DRD1 P21728 3/20 0.61
DRD3 P35462 3/20 0.61
DRD4 P21917 2/20 0.61
DRD5 P21918 2/20 0.61
DRD2 P14416 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
ALDH1A1 P00352 2/20 0.61
HPGD P15428 1/20 0.61
HTT P42858 1/20 0.61
TDP1 Q9NUW8 1/20 0.60
KDM4E B2RXH2 1/20 0.57
RAD52 P43351 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C19 P33261 1/20 0.56
HSD17B10 Q99714 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8481677 0.98 TSHR (0.61) TSHRMEN1KMT2AHRH1DRD1
Water SCHEMBL8479959 0.98 TSHR (0.61) TSHRMEN1KMT2AHRH1DRD1
SCHEMBL1892119 0.98 MEN1 (0.63) TSHRMEN1KMT2AHRH1DRD1
Hydrochloric Acid SCHEMBL8624615 0.97 MEN1 (0.62) TSHRMEN1KMT2AHRH1DRD1
SCHEMBL3570117 0.92 ALDH1A1 (0.62) MEN1KMT2AHRH1DRD1DRD3
Hydrochloric Acid SCHEMBL8622968 0.91 ALDH1A1 (0.61) MEN1KMT2AHRH1DRD1DRD3
SCHEMBL31528285 0.91 ALDH1A1 (0.64) MEN1KMT2AHRH1DRD1DRD3
Hydrochloric Acid SCHEMBL8908900 0.86 TSHR (0.58) TSHRMEN1KMT2AHRH1DRD1
SCHEMBL7324811 0.85 ALDH1A1 (0.57) TSHRMEN1KMT2AHRH1DRD1
SCHEMBL4224048 0.85 DRD1 (0.63) TSHRMEN1KMT2ADRD1DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5958969-A OSTEOPOROSIS ELI LILLY AND COMPANY (US) 1999-09-28 US claimed
EP-1222191-A2 BENZODIAZEPIN DERIVATIVES, THE PRODUCTION AND USE THEREOF BASF AKTIENGESELLSCHAFT (DE) 2002-07-17 EP disclosed
WO-2001023386-A2 BENZODIAZEPIN DERIVATIVES, THE PRODUCTION AND USE THEREOF BASF AKTIENGESELLSCHAFT (DE) 2001-04-05 WO disclosed
US-5958929-A CONGESTIVE HEART FAILURE; HYPOTENSIVE AGENTS SANOFI (FR) 1999-09-28 US disclosed
US-5958969-A OSTEOPOROSIS ELI LILLY AND COMPANY (US) 1999-09-28 US disclosed
US-5948795-A PLASMINOGEN ACTIVATOR INHIBITOR ELI LILLY AND COMPANY (US) 1999-09-07 US disclosed
US-5948796-A OSTEOPOROSIS, CANCER, CARDIOVASCULAR DISORDERS ELI LILLY AND COMPANY (US) 1999-09-07 US disclosed
US-5843984-A Sulfated benzothiophene derivatives, methods of use and formulations containing same ELI LILLY AND COMPANY (US) 1998-12-01 US disclosed
US-5827853-A MIXTURE CONTAINING PRODUCT FROM FERMENTATION BY STREPTOMYCES FOR TOPICAL APPLICATION TO SKIN OR HAIR, TO IMPROVE TEXTURE, SURFACE SMOOTHNESS, FIRMNESS SANOFI (FR) 1998-10-27 US disclosed
US-5798351-A USEFUL FOR INHIBITING BONE LOSS, LOWERING SEUM CHOLESTEROL LEVELS AND TREATING HORMONE DEPENDENT MAMMALIAN BREAST AND UTERINE CANCER ELI LILLY AND COMPANY (US) 1998-08-25 US disclosed
US-5736548-A CYCLIC GUANOSINE 3*,5*-MONOPHOSPHATE PHOSPHODIESTERASE INHIBITORS; TREATING HEART FAILURE, HYPERTENSION SANOFI (FR) 1998-04-07 US disclosed
US-5731342-A FOR TREATING AND PREVENTING POSTMENOPAUSAL SYNDROME AND BREAST CANCER ELI LILLY AND COMPANY (US) 1998-03-24 US disclosed
EP-0339483-A2 Renin inhbiting amino-acid derivatives MERCK PATENT GmbH (DE) 1989-11-02 EP disclosed
EP-0058890-B1 ANTITHROMBOTIC COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1984-09-26 EP disclosed
EP-0058890-A1 Antithrombotic compounds THE WELLCOME FOUNDATION LIMITED (GB) 1982-09-01 EP disclosed